Teva Pharmaceutical Industries Limited News Headlines

TEVA 
$56.86
*  
0.70
1.22%
Get TEVA Alerts
*Delayed - data as of Jan. 30, 2015  -  Find a broker to begin trading TEVA now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Teva Gains FDA Nod for Generic of AstraZeneca's Nexium - Analyst Blog
1/28/2015 6:10:00 PM - Zacks.com


Teva Gains FDA Nod for Generic of AstraZeneca's Nexium - Analyst Blog
1/28/2015 6:10:00 AM - Investopedia


Bristol-Myers Beats on Q4 Earnings, 2015 View Disappoints - Analyst Blog
1/27/2015 10:51:00 AM - Investopedia


Bristol-Myers Beats on Q4 Earnings, 2015 View Disappoints - Analyst Blog
1/27/2015 10:51:00 AM - Zacks.com


Update: Teva Set To Launch Generic Nexium, Outlook Positive
1/27/2015 8:40:00 AM - Seeking Alpha


What Investors Should Do About Imminent Obesity Drug Approvals In Europe
1/27/2015 8:38:00 AM - Seeking Alpha


Supernus Files Oxtellar XR Patent Infringement Lawsuit Again - Analyst Blog
1/26/2015 4:00:00 PM - Zacks.com


Teva Obtains FDA Approval For First Generic Nexium Delayed-Release Capsules
1/26/2015 3:41:00 PM - RTT News


FDA Rejects Antares'' Application for Generic Migraine Drug
1/26/2015 7:54:00 AM - Dow Jones Business News


FDA Rejects Antares' Application for Generic Migraine Drug
1/26/2015 7:54:00 AM - Dow Jones Business News


Antares Pharma Gets Complete Response Letter For Sumatriptan Injection USP
1/26/2015 7:18:00 AM - RTT News


Supernus Files Oxtellar XR Patent Infringement Lawsuit Again - Analyst Blog
1/26/2015 4:00:00 AM - Investopedia


Pharmaceutical industry supply chain
1/23/2015 4:06:00 PM - Market Realist


Classification of pharmaceutical subindustries
1/23/2015 12:06:00 PM - Market Realist


Global needs drive growth of pharmaceutical industry
1/23/2015 8:06:00 AM - Market Realist


Hess Corporation Bond Issue Leads Best Value 10-Year Bond Trades
1/22/2015 6:41:00 PM - Seeking Alpha


Teva Pharmaceutical: An Ambitious Bet
1/22/2015 3:37:00 PM - Seeking Alpha


SUPN In Legal Bout, NSPR Put On Notice, It''s Advantage TEVA, KTWO Gets FDA Nod
1/22/2015 12:48:00 AM - RTT News


Teva Up on Positive Copaxone Supreme Court Ruling - Analyst Blog
1/21/2015 4:00:00 PM - Zacks.com


Momenta Announces Supreme Court Decision To Remand Copaxone Case Back To CAFC
1/21/2015 8:57:00 AM - RTT News


Teva Up on Positive Copaxone Supreme Court Ruling - Analyst Blog
1/21/2015 4:00:00 AM - Investopedia


Teva Gets Favorable Ruling From U.S. Supreme In MS Drug Patent Case
1/20/2015 9:21:00 PM - RTT News


Supreme Court Sides With Teva in Patent Case on Copaxone -- 2nd Update
1/20/2015 4:57:00 PM - Dow Jones Business News


Update: Will Teva Lose Patent Protection For Copaxone After All?
1/20/2015 3:15:00 PM - Seeking Alpha


Supreme Court Sides With Teva in Patent Case on Copaxone -- Update
1/20/2015 12:44:00 PM - Dow Jones Business News